Merlin and ezrin are homologous proteins with opposite effects on neoplastic growth. Merlin is a tumor suppressor inactivated in the neurofibromatosis 2 disease, whereas upregulated ezrin expression is associated with increased malignancy. Merlin's tumor suppressor mechanism is not known, although participation in cell cycle regulation has been suggested. To characterize merlin's biological activities, we screened for molecules that would interact with merlin but not ezrin. We identified the cyclin Bbinding protein and cell cycle regulator HEI10 as a novel merlin-binding partner. The interaction is mediated by the alpha-helical domain in merlin and the coiled-coil domain in HEI10 and requires conformational opening of merlin. The two proteins show partial subcellular colocalization, which depends on cell cycle stage and cell adhesion. Comparison of Schwann cells and schwannoma cultures demonstrated that the distribution of HEI10 depends on merlin expression. In transfected cells, a constitutively open merlin construct affected HEI10 protein integrity. These results link merlin to the cell cycle control machinery and may help to understand its tumor suppressor function.
Introduction
Inherited mutations of the neurofibromatosis 2 (NF2) gene, which encodes for merlin, result in the development of numerous nervous system tumors; schwannomas, meningiomas and ependymomas, in the dominantly inherited NF2 disease (Louis et al., 1995) . Biallelic NF2 gene inactivation has also been demonstrated in other tumor types, especially mesotheliomas (Arakawa et al., 1994; Pineau et al., 2003) . The NF2 tumor suppressor protein merlin (schwannomin) is related to the ezrin-radixin-moesin (ERM) protein family. Ezrin-radixin-moesin proteins are associated with the actin cytoskeleton and cell membrane components and are involved in membrane structure morphogenesis, cell adhesion, membrane traffic, cell signaling and the regulation of cell growth (Bretscher et al., 2002) .
Inter-and intramolecular associations regulate merlin's functions and interactions with other proteins (Gonzalez-Agosti et al., 1999; Gro¨nholm et al., 1999) . Two types of kinases, PAK-1/2 and PKA have been shown to phosphorylate merlin at serine 518 and regulate its activity (Kissil et al., 2002; Xiao et al., 2002; Alfthan et al., 2004) , but it is still unclear, whether the phosphorylation is sufficient to release the intramolecular bond between the N-terminal FERM domain and the C-terminus.
In spite of many studies, the tumor suppressor function of merlin is not yet understood. Some evidence indicates that merlin is involved in cell cycle control. Overexpression of merlin can inhibit cell proliferation (Lutchman and Rouleau, 1995; Sherman et al., 1997; Gutmann et al. 1999 ) and transfection of merlin into primary schwannoma and mesothelioma cells reduces proliferation and promotes G0/G1 arrest (Schulze et al., 2002; Xiao et al., 2005) . Conversely, suppression of merlin in tumor cells induces proliferation (Huynh and Pulst, 1996) and a targeted disruption of the NF2 gene results in increased cell proliferation and tumor formation (McClatchey, 2003) . In accordance with a role for merlin in cell cycle regulation, we recently demonstrated cell cycle-dependent nucleo-cytoplasmic shuttling of merlin (Muranen et al., 2005) . To get insight into merlin's mechanism of action in cell cycle control we exploited the fact, that in spite of structural homology, overlapping subcellular distribution, direct association and partially overlapping protein interactions, merlin and ezrin exert opposite effects on cell growth. Indeed, increased expression of ezrin is associated with enhanced cell growth and poor prognosis of malignant tumors (Geiger et al., 2000; Ma¨kitie et al., 2001; Khanna et al., 2004; Tynninen et al., 2004; Ilmonen et al., 2005) . To provide clues on how merlin exerts its growth regulatory activity, we therefore sought to identify binding partners which are specific for merlin or ezrin.
HEI10 is a recently identified cell cycle regulator in both yeast and vertebrate cells (Toby et al., 2003) . HEI10 encodes a 277 amino-acid protein, which consists of an N-terminal RING-finger motif characteristic of E3 ubiquitin ligase, a coiled-coil domain and a C-terminal domain with a VSPSR motif, which is phosphorylated by cyclin B/cdc2. The N-terminal part of HEI10 interacts with the UbcH7 E2 ubiquitin conjugating enzyme and both interacts with and controls the accumulation of cyclin B, a key protein in cell cycle control (Toby et al., 2003) . The HEI10 gene is a component of a translocation fusion to the HMG1C gene in uterine leiomyoma (Mine et al., 2001 ) and altered HEI10 expression has been seen in melanomas (Smith et al., 2004) . These results imply that the deregulation of HEI10 may have consequences for tumor development. Here, we provide in vitro and in vivo evidence of a direct interaction between merlin and HEI10 and a role for merlin in regulation of HEI10 expression.
Results

Interaction of merlin and HEI10
To identify novel interaction partners specific for merlin but not ezrin we performed a yeast two-hybrid screen of a HeLa cell library using merlin 252-595 as bait. This construct was chosen instead of the full-length protein, since previous studies have shown that N-or Cterminally truncated merlin mimics an open conformation, where binding sites to other proteins are accessible (Gro¨nholm et al., 1999) . The screen identified HEI10 as a novel binding partner for merlin. In a mating assay merlin constructs 1-546 and 252-595, but not ezrin constructs 1-309 and 278-585, interacted with HEI10 ( Figure 1a) . To further study the interaction, in vitro binding assays were performed. In vitro translation (IVT)-produced merlin 1-595 (wt) or merlin 1-547, which have previously been shown to mimic a constitutively open conformation (Gro¨nholm et al., 1999) , was mixed with glutathione-coupled glutathione S-transferase (GST)-HEI10 46-277 or GST and bound proteins detected with SDS-PAGE and autoradiography. Glutathione S-transferase-HEI10 46-277 but not GST alone pulled down merlin 1-547 and merlin 1-595. In a reciprocal experiment, GST-merlin 1-547 but not GST alone pulled down IVT-produced HEI10 1-277 (wt) (Figure 1b) .
In an additional interaction test, HA-tagged merlin and ezrin constructs were produced in yeast and yeast lysates were used for pull down assays with glutathionebound GST-HEI10 46-277. Glutathione S-transferase-HEI10 46-277 pulled down merlin constructs 1-546 and 252-595, both of which contain the alpha-helical part of merlin. Full-length merlin or merlin constructs containing only the N-terminal domain 1-314 or the C-terminal domain 492-595, were not precipitated by (Figure 1c , for domain structure see Figure 3 ). Again, no association was seen between ezrin and HEI10.
The HEI10 rabbit antiserum is not functional in immunoprecipitations. Therefore, to study whether merlin and HEI10 interact in cells, 293HEK cells stably expressing merlin 1-595 (wt) or merlin 1-547 were transfected with HA-tagged HEI10. Cells were lysed 24 h after transfection and lysates immunoprecipitated with anti-HA monoclonal antibody (mAb). Filters were immunoblotted with merlin antibody or with anti-HA mAb. Merlin 1-547 (Figure 2b ), but not merlin wild type (wt) (Figure 2a) , could be coprecipitated with HA-HEI10. 
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Mapping of the merlin and HEI10 interaction sites
The yeast two-hybrid method and various merlin and HEI10 deletion constructs and mutants were used to further map the interaction sites in merlin and HEI10.
Only constructs containing the alpha-helical region of merlin interacted with HEI10 ( Figure 3a) . The region between merlin 306 and 339 contained critical residues, since the alpha-helical sequence 306-478 bound HEI10, but the N-terminal construct 1-314 or C-terminal construct 339-595 did not. A HEI10 construct containing the coiled-coil domain (residues 116-200) was sufficient for the interaction, while neither the Nterminal RING-finger domain nor the C-terminal domain containing the cyclin B/cdc2 phosphorylation site bound merlin. Binding was retained in merlin 252-595 with patient missense mutations L316T or L316W, or an amino-acid substitution (A468P), which completely disrupts the PKA-RIb-binding site (Gro¨nholm et al., 2003) . To further map the interaction site we created a transposon mutation library of merlin 1-546 with randomly introduced 15 bp in-frame insertions, each encoding five extra amino acids. Constructs were tested against HEI10 1-200 binding in the yeast two-hybrid system. Seven independent insertions within amino acids 275-326 disrupted binding of merlin to HEI10. Four of these insertions; at amino acids 306, 307, 318 and 326 localized within the previously mapped critical region, while two (275 and 283) were localized immediately before the interaction domain. One insertion within this region, at amino acid 277, did not affect binding. None of the other insertions prior to amino acid 275 at the end of the FERM-domain or the more C-terminal part of the alpha-helix affected HEI10 binding ( Figure 3b ).
Distribution of merlin and HEI10 in osteosarcoma cells
We recently demonstrated that the subcellular distribution of merlin is altered during adhesion and cell cycle progression in many cell types including U2OS osteosarcoma cells, which express both merlin (Muranen et al., 2005) and HEI10 (Toby et al., 2003) . To evaluate whether merlin and HEI10 are targeted in a similar fashion, cells were trypsinized and allowed to reattach. During early reattachment, both merlin and HEI10 were localized to the nucleus (Figure 4a ). However, as cells started to spread, merlin and HEI10 could be seen in punctuate structures at the plasma membrane. At this stage, a significant fraction of HEI10 was still present in the nucleus but most of the merlin immunoreactivity had exited the nucleus (Figure 4b ). When the cells were more fully spread, merlin and HEI10 could be seen in the submembranous compartment and diffusely in the cytoplasm (Figure 4c ).
The colocalization of merlin and HEI10 in U2OS cells is dependent on cell cycle stage In order to study the localization of HEI10 at different phases of the cell cycle, subconfluent U2OS cells were synchronized using nocodazole or mimosine treatment. FACS analysis was used to confirm the efficiency of synchronization and to monitor the cell cycle phase after block release (not shown). This experiment revealed that An interaction between merlin and HEI10 M Grönholm et al HEI10 localization varied in a cell cycle-specific manner. HEI10 colocalized with merlin in some but not all stages of the cell cycle ( Figure 5 ). In early G1 merlin and HEI10 were present in the nucleus but both proteins rapidly disappeared from the nucleus as cells progressed in G1. HEI10 returned to the nucleus in S-phase, remaining in this compartment until mitosis. In contrast, merlin remained at the cell periphery until late G2, at which state the protein accumulated in the perinuclear region. During the entire cell cycle a fraction of both proteins could also be found at the membrane. We recently showed that merlin is concentrated in the mitotic spindle of dividing cells and to the midbody during cytokinesis (Muranen et al., 2005) . In U2OS cells stained for HEI10, tubulin and DNA, also HEI10 associated with microtubules at the mitotic spindle and the contractile ring ( Figure 5 ).
The localization of HEI10 is dependent on merlin expression level To study if the distribution of HEI10 is dependent on the expression level of merlin, we compared the RT4 rat schwannoma cell line with a merlin-inducible RT4-5-4 variant ( Figure 6 ). RT4 cells express very low amounts of merlin, but expression of merlin can be induced with doxycycline in RT4-5-4 cells. In RT4 cells, HEI10 was seen in nuclei and diffusely in the cytoplasm, while weak merlin reactivity was detected underneath the cell membrane. RT4-5-4 cells with induced merlin expression showed a different HEI10 staining pattern. In some cells merlin and HEI10 colocalized in extensions and at the membrane (Figure 6f ). In around 10% of RT4-5-4 cells (an estimation from 500 counted cells) the nucleus was completely devoid of merlin and HEI10 (Figure 6f and f 0 ). Cells, in which merlin expression was not induced demonstrated strong nuclear HEI10 reactivity (Figure 6f and f 00 ). HEI10 localization was also studied in primary human schwannoma and Schwann cell cultures, which by immunoblotting were verified to express HEI10 (not shown). In schwannoma cells, which do not express merlin due to biallelic NF2 gene inactivation, HEI10 was frequently localized the nucleus (Figure 6h ) in line with rat schwannoma cells. On the other hand, in Schwann cells, which express merlin (not shown) HEI10 Figure 4 Localization of merlin and HEI10 in osteosarcoma cells. U2OS cells expressing endogenous merlin and HEI10 were trypsinated and allowed to reattach for 30 min (a), 1 h (b) or 2 h (c). Cells were fixed and stained with merlin IC4 monoclonal antibody (mAb) and HEI10 rabbit antiserum and images taken with an epifluorescence microscope. Both proteins are present primarily in the nucleus as cells are attaching. HEI10 persists in the nucleus longer than merlin during reattachment and spreading. A partial colocalization, particularly at the membrane (inset), can be seen in fully spread cells.
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The interaction with merlin affects HEI10 protein levels In order to gain insight into the potential functional interplay between merlin and HEI10, 293HEK cells were transfected with HA-HEI10 and merlin constructs 1-595 (wt), 1-547, 1-314 or 492-595, and expression levels of HEI10 and merlin assessed 72 h after transfections (Figure 7a ). Similar amounts of HEI10 were detected in cells coexpressing an empty pcDNA3 vector, merlin 1-314 or 492-595. However, cells coexpressing merlin 1-547 demonstrated a significantly reduced amount of HEI10 (P ¼ 0.0004), and a minor decrease was seen in cells coexpressing merlin 1-595 (wt) (P ¼ 0.019). Quantification of five experiments indicated an average 59% reduction of HEI10 in cells coexpressing merlin 1-547 in comparison to control cells, and a 23% reduction in cells coexpressing merlin 1-595 (wt).
To study whether binding to merlin is a requirement for the decrease, we tested the merlin 1-547 construct with an insertion at position 307, 1-547/ins307, which abolished HEI10 binding in the yeast two-hybrid experiment. Merlin 1-547/ins307, 1-547 or 1-595 (wt) was co-transfected with HEI10. In contrast to merlin 1-547, which resulted in a significant decrease of the HEI10 protein, the effect of 1-547/ins307 on HEI10 protein levels was much weaker, but comparable to that of merlin 1-595 (wt) (Figure 7b ), although all merlin constructs were expressed at similar levels.
To study the time dependence of merlin-induced degradation of HEI10, 293HEK cells were transfected with merlin 1-547 and HA-HEI10, and lysed at various Figure 5 Localization of merlin and HEI10 at different stages of the cell cycle. (a) U2OS cells were synchronized using nocodazole or mimosine treatment and the block was released. Cells in early and late G1, S and late G2 phase were stained with merlin 1C4 monoclonal antibody (mAb) and HEI10 rabbit antiserum and images taken with an epifluorescence microscope. Nuclear merlin and HEI10 can be seen at early G1 (arrows) after which nuclear merlin and most nuclear HEI10 disappear (arrows). HEI10 shuttles into the nucleus at the onset of S phase (arrow) where it is present until mitosis, while merlin accumulates perinuclearly at late G2 phase (arrow). (b) Mitotic cells were stained with HEI10 rabbit antiserum, tubulin mAb and DAPI to detect DNA and images taken with a confocal microscope. HEI10 can be seen in the mitotic spindle of a dividing cell and the contractile ring in a cell undergoing cytokinesis (arrow).
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In additional experiments, 293HEK cells stably expressing merlin 1-547 or vector only, were transiently transfected with HA-HEI10 or untagged HEI10. Cells were lysed after 60 h, HA-HEI10 detected with anti-HA mAb and untagged HEI10 with the HEI10 rabbit antiserum (Figure 7d ). In cells expressing the constitutively open merlin 1-547, the level of HEI10 was reduced compared to empty vector. Interestingly, in these cells a smaller B22 kDa protein band could be detected by the HEI10 Ab. This was apparently a degradation product, which was not detected with anti-HA mAb in HA-HEI10-transfected cells.
Discussion
Resolution of the tumor suppressor mechanism of the NF2 gene product merlin requires knowledge of its molecular interactions. In this respect, molecules that link merlin to cell cycle regulation are of special interest. In order to find explanations for the opposite effects merlin and ezrin play on cell proliferation we have Figure 6 Expression of merlin changes the subcellular localization of HEI10 in Schwann cell derivatives. RT4 rat schwannoma cells, expressing low amounts of merlin (a-c) and RT4-5-4 schwannoma cells induced to express merlin with doxycyclin (d-f) were stained for merlin with 1C4 monoclonal antibody (mAb) and HEI10 with rabbit antiserum and images taken with a confocal microscope. HEI10 is present in the nucleus of all cells with low merlin expression (c). Cells with high merlin expression are devoid of nuclear HEI10 (f and f 0 ), whereas those RT4-5-4 cells, which express very little merlin, show strong nuclear HEI10 staining (f and f 00 ). Merlin-positive primary human Schwann cells (g) and merlin-negative schwannoma cells (h) were stained for HEI10 with HEI10 rabbit antiserum. Nuclear HEI10 is seen in NFÀ/À cells but not in NF þ / þ cells (arrows).
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M Grönholm et al focused on molecular interactions that would be specific for either protein. With this approach, we identified the cell cycle regulator HEI10 as a protein that binds merlin but not ezrin. The interaction, which was verified by yeast twohybrid, affinity precipitation, and coimmunoprecipitation experiments is mediated between coiled-coil domains on both proteins. Such domains are frequently involved in protein interactions, in particular during protein oligomerization (Burkhard et al., 2001) . Interestingly, although the sequence in ezrin is very similar (B90% identity) to the corresponding region in merlin, ezrin does not bind HEI10. Only few interaction partners are known to bind the alpha-helical part of merlin. One of them is the regulatory subunit RIb of PKA (Gro¨nholm et al., 2003) . An amphipatic helix disrupting mutation, which inhibits merlin-PKA-RIb binding, did not affect HEI10 interaction suggesting that the interactions do not compete with each other. Two NF2 patient missense mutations, L316W and L316F (http://uwcmml1s.uwcm.ac.uk/uwcm/mg/nf2/, 2005) have been identified within residues 306-339, which is the critical sequence in merlin. These mutations did not, however, affect binding to HEI10, which indicates that disruption of the interaction is not the likely cause of NF2 in these patients. The PAK1 kinase, which is essential for the malignant growth of NF2 genedeficient cells, is controlled by merlin through two separate binding domains (Hirokawa et al., 2004) . Interestingly, the HEI10 binding domain lies within one of them, comprising of amino acids 288-359. Our results also indicate that the association between merlin and HEI10 needs conformational activation of merlin. In yeast two-hybrid and coimmunoprecipitation experiments of transfected 293HEK cells, merlin wt did not bind HEI10. However, merlin 1-547 could be coprecipitated with HEI10 from transfected cells and an N-or C-terminally truncated merlin construct, interacted with HEI10 in the two-hybrid experiment. We have previously shown that N-and C-terminal merlin constructs, including merlin 1-546, mimic an open conformation of merlin, and interact with proteins, which in vivo need conformational activation of merlin (Gro¨nholm et al., 1999 (Gro¨nholm et al., , 2003 . In vitro translation-produced merlin 1-595 could be pulled down by GST-HEI10, but this product might not represent the full-length protein, as the Cterminus of recombinant ERM proteins is easily degraded, and such degradation results in loss of the An interaction between merlin and HEI10 M Grönholm et al intramolecular bond between N-and C-terminus (Chambers and Bretscher, 2005) .
Many of the known tumor suppressors undergo nucleo-cytoplasmic shuttling as an efficient, simple and rapid way to control cell growth (Fabbro and Henderson, 2003) . Merlin is typically localized to cortical actin structures in patterns that partly overlap with ERM proteins (Gonzalez-Agosti et al., 1996; Sainio et al., 1997; Shaw et al., 1998) . However, it can also be targeted to the nucleus dependent on the cell cycle phase, cell density and adhesive state (Muranen et al., 2005) . In this study we show that also HEI10 localizes to the nucleus in a cell cycle-dependent manner and to the cortical actin cytoskeleton. The partial colocalization between merlin and HEI10 can indicate functional interplay between merlin and HEI10 in certain cell cycle phases. Nucleo-cytoplasmic shuttling may provide means for merlin and HEI10 to affect cell growth, although no nuclear function for either protein has been identified yet.
In a recent report, expression of merlin in a NF2 genedeficient mesothelioma cell lines caused accumulation of cells in G1 concomitant with a decreased expression of cyclin D1, inhibition of Cdk4 activity and dephosphorylation of Rb, which are important steps for G1/ S transtition. This decrease was caused by merlin's inhibitory effect on PAK, a known upstream activator of cyclin D1 transcription (Xiao et al., 2005) . The current results link merlin to cyclin B and thus to another control point of the cell cycle. Further studies are needed to find out, whether the pathways are regulated independently or in parallel.
Schwannomas are the primary manifestation of NF2. Therefore, it is of interest that Schwann cells express HEI10 and that its distribution depends on the expression of merlin. In human and rat schwannoma cells deficient for merlin expression, HEI10 was targeted to the nucleus, whereas in human Schwann cells and in rat schwannoma cells expressing increased levels of merlin, HEI10 was cytoplasmic. The results indicate that merlin is, either directly or indirectly, involved in targeting of HEI10. An indirect effect might result from the fact that merlin expressing cells are more frequently in G1 than merlin-negative cells (Schulze et al., 2002) , and during G1 HEI10 was shown to have mainly cytoplasmic location. Since both proteins are exported from the nucleus at a similar time frame during G1, it is also possible that merlin contributes to the transport of HEI10 from the nucleus. Our interpretation is that in cells deficient for merlin, the function of HEI10 is compromised due to inappropriate targeting.
Interestingly, the constitutively open form of merlin affected the integrity of the HEI10 protein. Coexpression of merlin 1-547 with HEI10 resulted in degradation of HEI10 with a mechanism that required binding between the two proteins. The mechanism of degradation is not yet clear. HEI10 can be ubiquitinated and can function as an E3 ubiquitin ligase (Toby et al., 2003) . However, preliminary experiments with proteasome inhibitors did not affect the degradation induced by constitutively open merlin.
Previously, models for the tumor suppressor role of merlin at the membrane-cytoskeleton interphase have been proposed. We have shown a more versatile localization of merlin, which is regulated by cell cycle phase, and demonstrate here an association between merlin and the cell cycle regulator. This suggests that merlin performs several functions in cells, which may all be linked to its function as a tumor suppressor.
Materials and methods
Antibodies and probes 1C4 mAb (Gonzalez-Agosti et al., 1996 ), KF10 mAb (den Bakker et al., 1995 and A19 or C18 rabbit antiserum (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) were used to detect merlin. The anti-HEI10 antibody has been described (Toby et al., 2003) . In addition, we used anti-HA antibody (Covance Inc., Princeton, NJ, USA), anti-a-tubulin mAb N356 (Amersham Pharmacia Biotech, Buckinghamshire, UK), DAPI to stain DNA (Sigma, St Louis, MO, USA) and propidium iodide (Sigma).
Cell cultures and stainings U2OS human osteosarcoma cells were cultured in McCoy's medium supplemented with 15% fetal bovine serum, and 293HEK cells in RPMI medium with 10% FBS and RT4 and RT4-5-4 rat schwannoma cells (Morrison et al., 2001) in DMEM medium with 10% FBS. Expression of merlin in RT4-5-4 cells was induced by 1 mg/ml doxycycline (Orion Pharma, Espoo, Finland) for 24 h. Since merlin expression affects RT4-5-4 cell proliferation in confluent cells (Morrison et al., 2001 ), cells were not allowed to grow to confluency. 293HEK cultures stably expressing full-length merlin (1-595, wt), merlin 1-547 or empty pcDNA3 vector (Invitrogen, Carlsbad, CA, USA) were produced by selection in 100 mg/ml hygromycin (Gibco). Cells were fixed in 3.5% paraformaldehyde (PFA), pH 7.4, and stained with 1C4 mAb (1:100) or A19 rabbit antiserum (1:200) to detect merlin and with anti-HEI10 rabbit antiserum (1:50) to detect HEI10 followed by Alexa488 anti-mouse or Alexa594 anti-rabbit antibodies (Molecular Probes, Eugene, OR, USA). Coverslips were mounted in DABCO (Sigma) and Mowiol (Calbiochem, San Diego, CA, USA) and examined by confocal microscopy (Leica SP2, Leica Microsystems, Heerbrugg, Switzerland) using the sequential scanning mode, or by immunofluorescence microscopy (Zeiss Axiophot epifluorescence microscope equipped with AxioCam cooled CCDcamera, Carl Zeiss, Esslingen, Germany).
Normal human Schwann and schwannoma cells were isolated as previously described Rosenbaum et al., 1998) . Following collection, cells were resuspended in proliferation medium (DMEM, 10% fetal calf serum, 500 U/ml penicillin/streptomycin (Gibco), 0.5 mM forskolin (Sigma), 10 nM b1-heregulin177-244 (Mark Sliwkowski, Genentech, San Francisco, CA, USA), 0.5 mM 3-isobutyl-1-methylxanthine (Sigma), 2.5 mg/ml insulin (Sigma)). Cells were seeded on plates pre-coated with 1 mg/ml poly-L-lysine (Sigma) and 4 mg/ml natural mouse laminin (Gibco). Cells were fixed by 4% PFA, permeabilized with 0.2% Triton X-100 for 5 min and blocked in 10% goat serum/1% bovine serum albumin in phosphate-buffered saline, before incubation with the HEI10 rabbit antiserum overnight at 41C and goat-anti-rabbit Cy3 1:800 (Dianova) for 40 min. Cells were analysed on a confocal scanning microscope (LSM510, Leica), and experiments were repeated three times using cell cultures from different donors each.
Production of glutathione S-transferase-fusion proteins Glutathione S-transferase-fusion proteins were expressed in Escherichia coli (DH5a) and purified following standard protocols. Fusion proteins were eluted from glutathioneSepharose (G-Sepharose) beads by 5 mM reduced glutathione in 50 mM Tris-HCl, pH 8 over night at 41C.
In vitro translation
Merlin pcDNA3 plasmids were used as a template for a T7-coupled rabbit reticulocyte transcription-translation system (Promega, Madison, WI, USA) in the presence of 35 Smethionine (Sigma). Of 50 ml reaction, 5 ml were separated in SDS-PAGE, the gel was dried and exposed on film to determine the size and amount of labelled protein. Fusion proteins on glutathione beads (B1 mg) were mixed with IVTproduced protein. Bound proteins were separated in SDS-PAGE, and detected with autoradiography.
Affinity precipitation
Yeast expressing HA-tagged merlin constructs were lysed with a mini beadbeater (BioSpec Products Inc., Bartlesville, OK, USA) in the presence of 1 ml acid-washed glass beads (Sigma) in 200 ml of ELB-buffer (50 mM Hepes, pH 7.4, 150 mM NaCl, 5 mM EDTA), 1% NP-40 and protease inhibitors. Debris was removed by centrifugation, and supernatant diluted to ELB-0.5% NP-40. Total protein (200 mg) from lysates were incubated with purified GST-fusion protein bound to GSepharose beads (0.5-1 mg) for 45 min. Beads were washed in ELB-0.1% NP-40 buffer and bound proteins eluted by boiling in non-reducing Laemmli sample buffer, separated in SDS-PAGE and analysed by immunoblotting. Bound proteins were detected with anti-HA antibody (1:3000).
Yeast two hybrid
A yeast two-hybrid screen was performed with merlin amino acids 252-595 cloned in the EG202 vector as bait using a HeLa cDNA library in the JG4-5 vector as described (Gyuris et al., 1993) . Merlin, ezrin and HEI10 constructs were cloned into EG202 and JG4-5 vectors. Mutations were introduced in merlin constructs using the QuickChange Kit (Stratagene, La Jolla, CA, USA) and their authenticity verified by sequencing. Yeast two-hybrid mating assays and detection of interactions were performed as described (Gro¨nholm et al., 1999) . Identification of the merlin coiled-coil domain was performed with COILS-prediction program (www.ch.embnet.org/software/COILS_form.html).
Merlin transposon mutation library
Merlin mutation library with random pentapetide insertions was constructed in the yeast two-hybrid vector pYesTrp2 (Invitrogen) containing merlin 1-546 using an in vitro DNA transposition-based peptide insertion mutagenesis system (Finnzymes Oy, Espoo, Finland). The library was transformed into yeast and interaction with HEI10 1-200 in the EG202 vector tested with the yeast two-hybrid mating assay (Gro¨n-holm et al., 1999) .
Cell transfections and Western blot analysis 293HEK cells were grown as above and transfected with a pcDNA3 vector expressing HA-HEI10, which contains 6 inserted HA-tags adding B90 amino acids to the expressed protein, or untagged HEI10 and different pcDNA3/merlin constructs using the Fugene transfection reagent (Roche, Mannheim, Germany). Transfected subconfluent cells were lysed after 24-90 h in 500 ml ELB-buffer (50 mM Hepes, pH 7.4, 150 mM NaCl, 5 mM EDTA), supplemented with 0.5% NP-40, protease and phosphatase inhibitors, and lysates normalized for protein concentration. Samples were separated in SDS-PAGE and analysed by immunoblotting using the anti-HA antibody (1:3000), HEI10 rabbit antiserum (1:50) or merlin A19 rabbit antiserum (1:1500). Proteins were detected with enhanced chemiluminescence. Western blot bands from five different experiments were analysed using the Image J imaging program and the mean values and standard deviation calculated.
Coimmunoprecipitation 293HEK cells stably expressing merlin 1-595 (wt), 1-547 or empty vector were transfected with the pcDNA3/HA-HEI10 construct, and lysed as above. Lysates were centrifuged at 15 000 g for 1 h at 41C. The supernatant was incubated with KF10 mAb, anti-HA mAb or X63, together with protein GSepharose beads (Amersham Biosciences, Uppsala, Sweden) for 4 h at 41C. Immunoprecipitates were washed with ELB-0.1% NP-40 and bound proteins were eluted from the beads by boiling in non-reducing Laemmli sample buffer. Precipitated proteins were detected as above.
Cell cycle studies For cell cycle synchronization, U2OS cells were treated with nocodazole (200-400 ng/ml, Calbiochem) or L-mimosine (200-400 mM, Calbiochem). After 18-24 h, the block was released. At various time points after release, samples were taken for immunofluorescence analysis as described.
